NeuroBo Pharmaceuticals, Inc. (NRBO) - Kompaniyaning xususiy kapitali
NeuroBo Pharmaceuticals (NRBO) metabolik tuzatishga e'tibor qaratgan holda, semizlik va jigarning yog'li kasalliklarini davolash vositalarini ishlab chiqishga ixtisoslashgan. Biznesning moliyaviy poydevori grantlar va tashqi kapitalga tayanadi, chunki joriy ko'rsatkich 0.02 darajasida turibdi. Aksiyaning narx grafigi aktivning dinamikasini aniq namoyish etadi. Tijorat mahsulotlarining yo'qligi va klinik sinovlarning joriy bosqichi barqaror pul oqimining mavjudligini istisno qiladi.
%20Kompaniyaning%20balans%20qiymati&width=1200&height=400&colorIndex=0&v=mvrk6wqv.ssk-7as46ww&start=20220704&end=20261028&filename=GURU_Markets_-_NRBO_-_NeuroBo-Pharmaceuticals_-_Company-Book-Value "NeuroBo Pharmaceuticals Inc (NRBO) Buxgalteriya kapitallashuvi: 04.07.2022 - 07.12.2024 davri uchun | 👁️GURU.Markets👁️")
NeuroBo Pharmaceuticals, Inc. (NRBO) kompaniyasi koʻrsatkichlari kesimi va tahlili
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning kapitalga nisbati NeuroBo Pharmaceuticals|NRBO - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzdorlikning kapitalga nisbati NeuroBo Pharmaceuticals Inc|NRBO - Kompaniya qarzlari|Balans qiymatiga qarzlar NeuroBo Pharmaceuticals Inc|NRBO - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli qarzdorligi NeuroBo Pharmaceuticals
Kompaniyaning jamlanma tahlili:NeuroBo Pharma - NRBO
Barqaror daromadga ega bo'lmagan biofarmatsevtika startapi sifatida NeuroBo Pharmaceuticals (NRBO) tashqi moliyalashtirishga tayanadi, bu esa sof aktivlar qiymatini uning yashab qolish imkoniyatining asosiy ko'rsatkichiga aylantiradi. Ushbu metrika umumiy aktivlardan majburiyatlarni ayiradi, bu esa kompaniyaning kitob kapitalizatsiyasi darajasiga biznesning haqiqiy moddiy bazasini aniqlash imkonini beradi. Ushbu fundamental ko'rsatkichni bozor narxi bilan solishtirish investorlarga qadrsizlangan aktivni klassik qiymat tuzog'idan ajratishga yordam beradi.
Asosiy raqobatchilar
BIIB: Kompaniyaning balans qiymati|Kompaniyaning balans qiymati NBIX|RGC (regencellbioscience.com) - Kompaniyaning xususiy kapitali|Kompaniyaning balans qiymati Axsome Therapeutics, Inc. (AXSM)|Buxgalteriya kapitallashuvi ACADIA Pharma|Xenon Pharmaceuticals Inc - Balans kapitallashuvi|Kompaniyaning xususiy kapitali Viking Therapeutics Corp VKTX|Kompaniyaning sof aktivlari SUPN (Supernus Pharmaceuticals)|catalystpharma.com - Balans kapitallashuvi|Kompaniyaning balans qiymati Denali Therapeutics Inc. (DNLI)|HRMY: Kompaniyaning buxgalteriya qiymati|Kompaniyaning balans qiymati BHVN|AMLX (Amylyx Corp) - Kompaniyaning xususiy kapitali|Kompaniyaning balans qiymati Trevi Therapeutics (TRVI)|Buxgalteriya kapitallashuvi praxismedicines.com|Anavex Life Sciences Corp. - Balans kapitallashuvi|Kompaniyaning xususiy kapitali CeriBell Inc CBLL|Kompaniyaning sof aktivlari PRTA (prothena.com)|Alector Inc. - Balans kapitallashuvi|Kompaniyaning balans qiymati Annexon, Inc. (ANNX)|OMER: Kompaniyaning buxgalteriya qiymati|Kompaniyaning balans qiymati NGNE|AC Immune S.A. (ACIU) - Kompaniyaning xususiy kapitali|Balans kapitallashuvi Voyager Pharma|Kompaniyaning balans qiymati NMRA|Scilex Holding Company - Kompaniyaning balans qiymati|Kompaniyaning xususiy kapitali tevogen.com TVGN|Kompaniyaning sof aktivlari Alpha Cognition Inc.|cogrx.com - Kompaniyaning buxgalteriya qiymati|Kompaniyaning balans qiymati Inhibikase|SAVA - Sof aktivlar qiymati|Balans kapitallashuvi assertiotx.com ASRT|Coya Therapeutics (COYA) - Kompaniyaning buxgalteriya qiymati|VTGN (VistaGen Therapeutics, Inc.) - Balans kapitallashuvi|Balans kapitallashuvi OVID|Acumen Pharma (ABOS) - Kompaniyaning balans qiymati|Kompaniyaning buxgalteriya qiymati CRVO (CervoMed Corporation)|Alterity Therapeutics Limited - Kompaniyaning balans qiymati|Kompaniyaning sof aktivlari Clene Inc CLNN|PepGen Corp - Balans kapitallashuvi|JUNS - Balans kapitallashuvi|RLMD (Relmada) - Balans kapitallashuvi|Annovis Bio Corporation (ANVS) - Kompaniyaning sof aktivlari|Balans kapitallashuvi GRCE (Grace Therapeutics Inc)|Kompaniyaning xususiy kapitali fireflyneuro.com (AIFF)|Kompaniyaning sof aktivlari KLTO|Balans kapitallashuvi neurosense-tx.com NRSN|Kompaniyaning sof aktivlari Reviva Pharmaceuticals Holdings (RVPH)|Jami sof aktivlar MetaVia Inc. MTVA|Balans kapitallashuvi NRXS (NeurAxis, Inc.)|HSDT - Biznesning balans bahosi|PASG (passagebio.com) - Balans kapitallashuvi|Neuphoria Therapeutics (NEUP) - Kompaniyaning sof aktivlari|NERV (Minerva Neurosciences Corp) - Balans kapitallashuvi|Balans kapitallashuvi ATHA|Kompaniyaning balans qiymati Addex Therapeutics (ADXN)|Kompaniyaning balans qiymati ALZN (alzamend.com)|Kompaniyaning balans qiymati CYCN|Protagenic Therapeutics Inc. - Biznesning balans bahosi|Pasithea (KTTA) - Kompaniyaning balans qiymati|CRGT: Buxgalteriya kapitallashuvi|Kompaniyaning balans qiymati Avenue Therapeutics ATXI|brainstorm-cell.com (BCLI) - Kompaniyaning buxgalteriya qiymati|Balans kapitallashuvi Cara Therapeutics|Kompaniyaning balans qiymati CHRO|Eliem Therapeutics - Kompaniyaning balans qiymati|Kompaniyaning xususiy kapitali ITCI (intracellulartherapies.com)|LBPH - Kompaniyaning balans qiymati|Buxgalteriya kapitallashuvi marinuspharma.com MRNS|NKGN (NKGen Biotech) - Balans kapitallashuvi|Sage Therapeutics Inc. (SAGE) - Kompaniyaning xususiy kapitali|SNPX: Kompaniyaning sof aktivlari|TRVN (Trevena Inc) - Balans kapitallashuvi|VIGL - Kompaniyaning balans qiymati|Kompaniyaning buxgalteriya qiymati WENA|Cerevel Therapeutics, Inc. - Kompaniyaning balans qiymati